The THRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the THRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The THRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View THRX Detailed Price Forecast - CNN Money | View THRX Detailed Summary - Google Finance | ||
View THRX Detailed Summary - Yahoo! Finance | View THRX Stock Research & Analysis - Zacks.com |
View THRX Trends & Analysis - Trade-Ideas | View THRX Major Holders - Barrons | ||
View THRX Call Transcripts - NASDAQ | View THRX Breaking News & Analysis - Seeking Alpha | ||
View THRX Annual Report - CompanySpotlight.com | View THRX OTC Short Report - OTCShortReport.com | ||
View THRX Fundamentals - TradeKing | View THRX SEC Filings - Bar Chart | ||
View Historical Prices for THRX - The WSJ | View Performance/Total Return for THRX - Morningstar | ||
View the Analyst Estimates for THRX - MarketWatch | View the Earnings History for THRX - CNBC | ||
View the THRX Earnings - StockMarketWatch | View THRX Buy or Sell Recommendations - MacroAxis | ||
View the THRX Bullish Patterns - American Bulls | View THRX Short Pain Metrics - ShortPainBot.com |
View THRX Stock Mentions - StockTwits | View THRX Stock Mentions - PennyStockTweets | ||
View THRX Stock Mentions - Twitter | View THRX Investment Forum News - Investor Hub | ||
View THRX Stock Mentions - Yahoo! Message Board | View THRX Stock Mentions - Seeking Alpha |
View Insider Transactions for THRX - SECform4.com | View Insider Transactions for THRX - Insider Cow | ||
View THRX Major Holdings Summary - CNBC | View Insider Disclosure for THRX - OTC Markets | ||
View Insider Transactions for THRX - Yahoo! Finance | View Institutional Holdings for THRX - NASDAQ |
View THRX Stock Insight & Charts - FinViz.com | View THRX Investment Charts - StockCharts.com | ||
View THRX Stock Overview & Charts - BarChart | View THRX User Generated Charts - Trading View |
Theseus Pharmaceuticals Announces Closing of Tender Offer
Posted on Wednesday February 14, 2024
Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus" or the "Company"), a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development, and commercialization of transformative targeted therapies, today announced that Concentra Biosciences, LLC ("Concentra") through its wholly owned subsidiary, Concentra Merger Sub II, Inc. ("Merger Sub"), has successfully completed the previously announced tender offer to acquire all outstanding
Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals
Posted on Tuesday January 30, 2024
SAN DIEGO, January 30, 2024--As previously announced on December 22, 2023, Concentra Biosciences, LLC ("Parent") and its wholly owned subsidiary, Concentra Merger Sub II, Inc. ("Purchaser"), entered into a merger agreement (the "Merger Agreement") with Theseus Pharmaceuticals, Inc. (Nasdaq: THRX) ("Theseus") whereby Purchaser will acquire Theseus for a price per share of Theseus common stock ("Theseus common stock") between $3.90 and $4.05 in cash, consisting of (i) a base cash price of $3.90 pe
Is Theseus Pharmaceuticals (THRX) Stock a Solid Choice Right Now?
Posted on Friday December 29, 2023
Theseus Pharmaceuticals (THRX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right
Posted on Friday December 22, 2023
Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus" or the "Company"), a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development, and commercialization of transformative targeted therapies, today announced it has entered into a definitive merger agreement (the "Merger Agreement") whereby Concentra Biosciences, LLC ("Concentra") will acquire Theseus for a price per share of Theseus common stock ("Theseus common stock") of b